Fractional contract engagement | Approximately 20–30 hours per month
About the Company
Our client A biotech team developing a GLP-1 therapy using a polymeric nanoparticle delivery platform. Its development program includes spray-dried powder formulations and is supported by an external CDMO partner.
The Opportunity
The company is seeking an experienced CMC leader to provide fractional technical and strategic leadership as it advances its GLP-1 program toward clinical manufacturing. The strongest candidate will bring direct experience developing polymeric nanoparticles, including PLGA or comparable systems, and spray-drying nanoparticle formulations. This person will work closely with the CDMO and internal team to guide scale-up, technology transfer, process controls, and readiness for GMP clinical batches.
This is an approximately 20–30-hour-per-month contract engagement. The CDMO will lead much of the day-to-day manufacturing and scale-up work; this leader will provide the technical judgment, oversight, and follow-through needed to ensure the process is successfully transferred and advanced.
Key Responsibilities
- Provide CMC leadership for polymeric nanoparticle and spray-dried powder development, with emphasis on practical decisions that support scale-up and clinical supply.
- Guide formulation and process development for PLGA or comparable polymeric nanoparticles, including critical process parameters, particle attributes, encapsulation, stability, and performance.
- Lead technical strategy for spray-drying nanoparticle suspensions into a suitable powder formulation; assess process parameters and relevant powder attributes, including moisture, redispersibility, particle properties, and delivery performance.
- Partner with the CDMO to plan and oversee technology transfer, process scale-up, troubleshooting, and preparation for GMP manufacturing.
- Ensure development work supports successful production of preclinical and clinical trial batches, including appropriate process documentation, specifications, and controls.
- Establish and review critical quality attributes, analytical methods, raw material controls, and phase-appropriate process controls for nanoparticle and powder products.
- Work directly with company leadership and cross-functional partners to identify risks, make recommendations, and drive decisions and action items to completion.
- Contribute CMC strategy and technical content for regulatory submissions, including IND-enabling and clinical-stage documentation.
Required Qualifications
- Advanced degree in pharmaceutical sciences, chemical engineering, materials science, chemistry, or a related discipline; equivalent industry experience may be considered.
- At least 10 years of progressive pharmaceutical CMC or product development experience.
- Direct, in-depth experience developing polymeric nanoparticles, including PLGA or comparable polymer systems.
- Direct experience with spray drying for pharmaceutical formulations, ideally spray-drying nanoparticle suspensions into powder.
- Demonstrated experience scaling processes and transferring them to external manufacturing partners, with a clear understanding of the path to GMP and clinical trial batches.
- Strong technical depth in formulation and process development, analytical characterization, process controls, and CDMO oversight.
- Ability to work independently in a fractional role, engage in technical detail, make clear recommendations, and actively move work forward with external partners.
Preferred Qualifications
- Experience with inhaled or intranasal products and an understanding of powder delivery performance or related device considerations.
- Experience in an early-stage biotech or with a lean development team.
- Prior fractional or consulting CMC leadership experience.
- Experience supporting IND submissions and GMP manufacturing of clinical supply.
Contract engagement averaging approximately 20–30 hours per month. The role will work closely with company leadership and its external CDMO partner; the specific schedule can be coordinated around program needs.